Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/26815
Type
ArticleCopyright
Restricted access
Embargo date
2060-01-01
Collections
Metadata
Show full item record
ENHANCED ACTIVATION OF EOSINOPHILS IN PERIPHERAL BLOOD AND IMPLICATIONS FOR EOSINOPHILIC ESOPHAGITIS DIAGNOSIS.
Author
Affilliation
Universidade de Brasilia. Faculdade de Medicina. Laboratorio de Imunologia Celular. Brasilia, DF, Brasil/Clinica Alergya. Brasilia, DF, Brasil
Universidade de Brasilia. Faculdade de Medicina. Laboratorio de Imunologia Celular. Brasilia, DF, Brasil
Fundação Oswaldo Cruz. Instituto Rene Rachou. Grupo de Imunologia Molecular Celular. Belo Horizonte, MG, Brazil
Universidade de Brasilia. Faculdade de Medicina. Laboratorio de Imunologia Celular. Brasilia, DF, Brasil
Laboratorio Brasiliensis. Brasilia, DF, Brasil/Universidade Catolica de Brasília. Brasília, DF, Brasil
Universidade de Brasilia. Faculdade de Medicina. Laboratorio de Imunologia Celular. Brasilia, DF, Brasil
Universidade de Brasilia. Faculdade de Medicina. Laboratorio de Imunologia Celular. Brasilia, DF, Brasil
Fundação Oswaldo Cruz. Instituto Rene Rachou. Grupo de Imunologia Molecular Celular. Belo Horizonte, MG, Brazil
Universidade de Brasilia. Faculdade de Medicina. Laboratorio de Imunologia Celular. Brasilia, DF, Brasil
Laboratorio Brasiliensis. Brasilia, DF, Brasil/Universidade Catolica de Brasília. Brasília, DF, Brasil
Universidade de Brasilia. Faculdade de Medicina. Laboratorio de Imunologia Celular. Brasilia, DF, Brasil
Abstract
Background and Aim: Eosinophils are markers of the eosinophilic esophagitis (EoE) disease, and this work aimed to assess whether activation of eosinophils could be a noninvasive test to contribute for EoE diagnosis.
Methods: The activation state of peripheral blood eosinophils in EoE patients and control subjects was assessed based on the morphological aspects of the eosinophil after adherence to slide. Cyclooxygenase-2 and 5-lipoxygenase expressions were evaluated by means of immunofluorescence microscopy to verify if and which eicosanoid pathway is triggered in eosinophils in blood in EoE.
Results: The eosinophils of patients with EoE were significantly more activated than those of control individuals. The lowest percentage of normal eosinophils for control subjects was 40%, while the highest percentage of eosinophils of normal aspect for patients with EoE was 32%. Considering 36% as a cutoff for normal eosinophils, this value differentiated all individuals with EoE from individuals without the disease with a sensitivity of 100%, considering the diagnosis of EoE as currently defined. Eosinophils of EoE patients showed higher expression of cyclooxygenase-2 than those of control subjects.
Conclusions: The quantification of morphological changes in eosinophils is a feasible,easy, and reliable manner to identify EoE patients. Therefore, patients with symptoms of esophageal dysfunction showing higher than 36% activated eosinophils in peripheral blood could be a useful way to help definition and diagnostic criterion for EoE.
Share